Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.
Authors:
- G W GlaznerGGG W Glazner
- I GozesIGI Gozes
- D E BrennemanDBD E Brenneman
- J M HillJHJ M Hill
Open Access
- 15 June 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 99 (12) , 2837-2841
Abstract
Intrauterine growth retardation and neurodevelopmental handicaps are common among infants born to HIV-positive mothers and may be due to the actions of virions and/or maternally derived viral products. The viral envelope protein, gp120, is toxic to neurons, induces neuronal dystrophy, and retards behavioral development in neonatal rats. Vasoactive intestinal peptide, a neuropeptide regulator of early postimplantation embryonic growth, and the neuroprotective protein, activity-dependent neurotrophic factor, prevent gp120-induced neurotoxicity. Whole embryo culture of gestational day 9.5 mouse embryos was used to assess the effect of gp120 on growth. Embryos treated with gp120 exhibited a dose-dependent inhibition of growth. gp120-treated embryos (10(-8) M) grew 1.2 somites in the 6-h incubation period, compared with 3.9 somites by control embryos. Embryos treated with gp120 were significantly smaller in cross-sectional area and had significantly less DNA and protein than controls. Growth inhibition induced by gp120 was prevented by cotreatment with vasoactive intestinal peptide or activity-dependent neurotrophic factor. gp120 may play a role in the growth retardation and developmental delays experienced by infants born to HIV-positive mothers. Vasoactive intestinal peptide and related factors may provide a therapeutic strategy in preventing developmental deficits.Keywords
This publication has 61 references indexed in Scilit:
- In VivoTrapping of Nitric Oxide in the Brain of Neonatal Rats Treated with the HIV-1 Envelope Protein gp 120: Protective Effects of α-Phenyl-tert-butylnitroneBiochemical and Biophysical Research Communications, 1996
- The Effect of Human Immunodeficiency Virus Infection on Birthweight, and Infant and Child Mortality in Urban MalawiInternational Journal of Epidemiology, 1995
- Impact of maternal HIV‐1 infection on perinatal outcomeInternational Journal of Gynecology & Obstetrics, 1995
- Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.Journal of Clinical Investigation, 1994
- Molecular Mechanisms of Nitric Oxide Actions in the BrainaAnnals of the New York Academy of Sciences, 1994
- Perinatal transmission of HIV-I in Zambia.BMJ, 1989
- Perinatal Transmission of the Human Immunodeficiency Virus Type 1 to Infants of Seropositive Women in ZaireNew England Journal of Medicine, 1989
- Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.Journal of Cell Biology, 1987
- VERTICAL TRANSMISSION OF HIV IN 15-WEEK FETUSThe Lancet, 1986
- The Contribution of Low Birth Weight to Infant Mortality and Childhood MorbidityNew England Journal of Medicine, 1985